• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向紫杉醇前药纳米组装体提高肝癌治疗效果。

Targeted paclitaxel prodrug nanoassemblies to improve therapeutic effects for liver cancer.

机构信息

Key Laboratory of Jiangxi University for Applied Chemistry and Chemical Biology, Yichun University, Yichun 336000, PR China; College of Chemistry and Bio-engineering, Yichun University, Yichun 336000, PR China.

College of Chemistry and Bio-engineering, Yichun University, Yichun 336000, PR China.

出版信息

Colloids Surf B Biointerfaces. 2023 Jun;226:113285. doi: 10.1016/j.colsurfb.2023.113285. Epub 2023 Mar 30.

DOI:10.1016/j.colsurfb.2023.113285
PMID:37028229
Abstract

Prodrug nanoassemblies fabricated by anticancer drug conjugates exhibited more advantages in controlled drug release and bioavailability and favorable antitumor efficacy. In this paper, lactobionic acid (LA) was connected with polyethylene glycol through amido linkages, and paclitaxel was joined with polyethylene glycol by means of ester bonds to form the prodrug copolymer LA-PEG-PTX. Then, LA-PEG-PTX was automatically assembled into LA-PEG-PTX nanoparticles (LPP NPs) by dialysis. The LPP NPs had a relatively uniform size of approximately 200 nm, a negative potential (-13.68 mV), and a spherical shape under TEM. The drug loading of LPP NPs was 3.91%, which was measured by HPLC. The in vitro release profile of LPP NPs exhibited a sustained release feature. The results of the pharmacokinetic test in rats showed that LPP NPs had higher T and AUC values than the control group (free PTX) and a prolonged in vivo circulation time, thus increasing the bioavailability of PTX. Remarkably, the LPP NPs were absorbed into HepG2 cells after galactose-directed internalization and enhanced cytotoxicity. Consequently, LPP NPs displayed notable antitumor activity in Kunming mice with H22 hepatocellular carcinoma. Collectively, these findings suggested that paclitaxel prodrug-based self-assembled nanoparticles were a promising alternative for improving the bioavailability and antitumor effect of PTX.

摘要

前药纳米组装体由抗癌药物偶联物制备,在控制药物释放和生物利用度以及良好的抗肿瘤疗效方面表现出更多优势。在本文中,通过酰胺键将乳糖酸(LA)与聚乙二醇连接,通过酯键将紫杉醇与聚乙二醇连接,形成前药共聚物 LA-PEG-PTX。然后,通过透析将 LA-PEG-PTX 自动组装成 LA-PEG-PTX 纳米颗粒(LPP NPs)。LPP NPs 的粒径约为 200nm,具有负电位(-13.68mV),TEM 下呈球形。通过 HPLC 测量,LPP NPs 的载药量为 3.91%。LPP NPs 的体外释放曲线表现出持续释放的特征。大鼠药代动力学试验结果表明,LPP NPs 的 T 和 AUC 值均高于对照组(游离 PTX),体内循环时间延长,从而提高了 PTX 的生物利用度。值得注意的是,LPP NPs 通过半乳糖介导的内化被吸收到 HepG2 细胞中,并增强了细胞毒性。因此,LPP NPs 在昆明小鼠 H22 肝癌模型中表现出显著的抗肿瘤活性。总之,这些发现表明,基于紫杉醇前药的自组装纳米颗粒是提高 PTX 生物利用度和抗肿瘤效果的一种有前途的选择。

相似文献

1
Targeted paclitaxel prodrug nanoassemblies to improve therapeutic effects for liver cancer.靶向紫杉醇前药纳米组装体提高肝癌治疗效果。
Colloids Surf B Biointerfaces. 2023 Jun;226:113285. doi: 10.1016/j.colsurfb.2023.113285. Epub 2023 Mar 30.
2
Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.基于二硫键连接的聚乙二醇-药物偶联物的新型载游离紫杉醇氧化还原响应性纳米颗粒用于细胞内药物递送:合成、表征及体内外抗肿瘤活性
Mol Pharm. 2014 Oct 6;11(10):3656-70. doi: 10.1021/mp500399j. Epub 2014 Sep 24.
3
Probing the fluorination effect on the self-assembly characteristics, fate and antitumor efficacy of paclitaxel prodrug nanoassemblies.探究氟化物对紫杉醇前药纳米组装体自组装特性、命运和抗肿瘤功效的影响。
Theranostics. 2021 Jul 6;11(16):7896-7910. doi: 10.7150/thno.61337. eCollection 2021.
4
Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.用于肿瘤特异性递送紫杉醇的明确定义的氧化还原敏感型聚乙二醇-紫杉醇前药缀合物,使用奥曲肽进行肿瘤靶向。
Mol Pharm. 2015 Aug 3;12(8):3020-31. doi: 10.1021/acs.molpharmaceut.5b00280. Epub 2015 Jun 30.
5
Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.使用自组装纳米颗粒递送黄芩素和紫杉醇:体内外协同抗肿瘤作用
Int J Nanomedicine. 2015 May 22;10:3737-50. doi: 10.2147/IJN.S80297. eCollection 2015.
6
Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.载光敏剂聚乙二醇化的活性氧敏感前药纳米组装体用于核壳协同化学动力学治疗。
Acta Biomater. 2019 Jul 1;92:219-228. doi: 10.1016/j.actbio.2019.05.008. Epub 2019 May 9.
7
Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.载紫杉醇的聚乙二醇化明胶靶向纳米粒的研制及其在非小细胞肺癌(NSCLC)中的增效作用的体内外评价研究。
Acta Biochim Pol. 2021 Aug 6;68(4):583-591. doi: 10.18388/abp.2020_5431.
8
Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)-paclitaxel prodrug: In Vivo conversion and antitumor efficacy.含有低聚乳酸-紫杉醇前药的聚(乙二醇)-嵌段-聚(d,l-乳酸)胶束:体内转化及抗肿瘤疗效
J Control Release. 2019 Mar 28;298:186-193. doi: 10.1016/j.jconrel.2019.02.017. Epub 2019 Feb 18.
9
Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.负载高剂量紫杉醇 - 硅酸盐前药的纳米颗粒:制剂、药物释放及抗癌疗效
Mol Pharm. 2015 Dec 7;12(12):4329-35. doi: 10.1021/acs.molpharmaceut.5b00530. Epub 2015 Nov 4.
10
Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.乙酰化连接的紫杉醇前药胶束纳米粒作为一种通用且有效的癌症治疗平台。
Biomacromolecules. 2013 Aug 12;14(8):2772-80. doi: 10.1021/bm400615n. Epub 2013 Jul 1.

引用本文的文献

1
Efficacy and safety of paclitaxel combined with oxaliplatin in the treatment of advanced primary hepatocellular carcinoma.紫杉醇联合奥沙利铂治疗晚期原发性肝细胞癌的疗效与安全性
Am J Cancer Res. 2025 Mar 15;15(3):1122-1132. doi: 10.62347/ZKIG9938. eCollection 2025.
2
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases.用于治疗肝脏疾病的聚合物纳米颗粒的最新进展。
Front Pharmacol. 2025 Jan 24;16:1528752. doi: 10.3389/fphar.2025.1528752. eCollection 2025.
3
Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent.
新型替诺福韦衍生物的设计、合成与评价及其作为有效抗肝癌药物的研究。
Curr Pharm Des. 2024;30(27):2167-2178. doi: 10.2174/0113816128314500240621071306.
4
Developing risk models and subtypes of autophagy-associated LncRNAs for enhanced prognostic prediction and precision in therapeutic approaches for liver cancer patients.开发与自噬相关的长链非编码 RNA 的风险模型和亚型,以增强对肝癌患者的预后预测和治疗方法的精准性。
Oncol Res. 2024 Mar 20;32(4):703-716. doi: 10.32604/or.2023.030988. eCollection 2024.
5
Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma.基于天然药物单体的新型靶向给药系统抗肝细胞癌的研究进展
Heliyon. 2024 Jan 18;10(2):e24667. doi: 10.1016/j.heliyon.2024.e24667. eCollection 2024 Jan 30.